Department of Neurosurgery, CARE The Institute of Medical Sciences, Hyderabad, Andhra Pradesh, India.
Neurol India. 2011 Jul-Aug;59(4):558-65. doi: 10.4103/0028-3886.84338.
Pharmacological or neurosurgical therapies currently in practice to treat the damage in various neurodegenerative disorders are not efficient in preventing progression or cure of these progressive neurodegenerative processes. Recently, a new approach, cell therapy using stem cell, is being evaluated. However, the use of this therapy in the treatment of these neurological diseases is highly restricted, mainly owing to several technical difficulties and limitations. The strategy of isolation and characterization of neural stem cells from various sources will probably provide a major impetus and open up an interesting, novel therapeutic modality for several neurodegenerative disorders. The high regenerative potential of damaged neural tissues suggests that various embryonic/adult sources serve as a proxy for neural stem cells for cell-based therapy.
目前用于治疗各种神经退行性疾病损伤的药物或神经外科疗法在阻止这些进行性神经退行性过程的进展或治愈方面效果并不理想。最近,一种新的方法,即使用干细胞的细胞疗法,正在被评估。然而,这种疗法在治疗这些神经系统疾病方面的应用受到了高度限制,主要是由于存在若干技术困难和局限性。从各种来源分离和鉴定神经干细胞的策略可能会为多种神经退行性疾病提供主要的推动力,并开辟一种有趣的新型治疗模式。受损神经组织的高再生潜能表明,各种胚胎/成年来源可作为基于细胞的治疗的神经干细胞替代物。